semaglutide compounding news november 2025 FDA's GLP-1 decision kicks off 'unprecedented' tussle over shortage Pharmacy Policy: January 2025 |

Is compounded semaglutide FDA-approved for weight loss

CEO Geoff Tanner explained that the company recently concluded a pilot clinical study that found GLP-1 users consuming Atkins products had positive muscle mass retention, digestive comfort and improved metabolic markers that are important to consumers with diabetes

Compounded versions often include additives like vitamin B6 or other peptides, and dosing may differ from the branded equivalents

Ali wasnt involved in the study

Retatrutide targets 3 hormone pathways vs Ozempics 1, achieving 24% weight loss in trials

Weight Management at CU Medicine The best GLP-1 choice depends on a patients health history, preferences and access to treatment